Ardent Health, Inc. (ARDT) Stock Analysis

Q: What is the ARDT stock price target?

Take-profit $10.82 (+6.9% upside). Prior stop was $9.41.

Q: What are the risks of investing in ARDT?

Thin upside margin: 6.9%; Leverage penalty (D/E 1.4): -0.5; Earnings in 4 days (event risk); Reward/Risk 0.5:1 at current price — below 1.5:1 minimum; EARNINGS_PROXIMITY:4d<=7d.

Q: Is ARDT overvalued or undervalued?

Ardent Health, Inc. trades at a P/E of 10.2 (forward 8.4). TrendMatrix value score: 8.6/10. Overall verdict: Sell.

Q: What do analysts say about ARDT?

19 analysts cover ARDT with a consensus score of 3.9/5. Average price target: $12.

Recovery setup

SellModerate ConfidenceUpdated 2026-05-01

Healthcare · Medical Care Facilities

Earnings in 4 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $10.13, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 6.9%; Leverage penalty (D/E 1.4): -0.5.

$10.13+6.9% A.UpsideScore 5.4/10#11 of 27 Medical Care Facilities

Stop $9.41Target $10.82(analyst − 13%)A.R:R 0.5:1

Analyst target$12.44+22.8%11 analysts

$10.82our TP

$10.13price

$12.44mean

$15

Passes 5/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 4d<=7d. Suitability: aggressive.

Thesis

Rewards

Strong earnings beat streak (3/4)

Attractive valuation

Margin of safety: 32%

Risks

Thin upside margin: 6.9%

Leverage penalty (D/E 1.4): -0.5

Earnings in 4 days (event risk)

Key Metrics

P/E (TTM)10.2

P/E (Fwd)8.4

Mkt Cap$1.4B

EV/EBITDA7.1

Profit Mgn2.1%

ROE14.4%

Rev Growth-0.1%

Beta—

DividendNone

Rating analysts19

Quality Signals

Piotroski F7/9

Options Flow

P/C1.33bearish

IV94%elevated

Max Pain$25+146.8% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value8.615%1.29

Quality5.115%0.76

Growth4.415%0.66

Momentum5.810%0.58

Sentiment6.010%0.60

Insider Activity5.010%0.50

Peer Rank3.410%0.34

Technical Setup2.65%0.13

Risk Profile3.65%0.18

Catalyst6.75%0.34

Overall (Σ contributions)5.38

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger

1.1

Support Resistance

1.3

52w Position

3.1

Gap

5.0

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank

1.1

Quality Rank

3.6

Value Rank

9.0

Attractive P/E vs peers

GatesA.R:R 0.5 < 1.5@spotEARNINGS PROXIMITY 4d<=7dDeath cross (50MA < 200MA)Momentum 5.8>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRecoverySuitability: Aggressive

RSI

65 · Neutral

↑ 20D MA↑ 50D MA↓ 200D MADEATH CROSSSupport $8.60Resistance $10.34

Price Targets

$11

A.Upside+6.8%

A.R:R0.5:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Reward/Risk 0.5:1 at current price — below 1.5:1 minimum

! EARNINGS_PROXIMITY:4d<=7d

Earnings

3/4 beats

Next Earnings2026-05-05 (4d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is ARDT stock a buy right now?

Sell if holding. At $10.13, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 6.9%; Leverage penalty (D/E 1.4): -0.5. Chart setup: Death cross but MACD improving, RSI 65. Prior stop was $9.41. Score 5.4/10, moderate confidence.

What is the ARDT stock price target?

Take-profit target: $10.82 (+6.9% upside). Prior stop was $9.41. Stop-loss: $9.41.

What are the risks of investing in ARDT?

Thin upside margin: 6.9%; Leverage penalty (D/E 1.4): -0.5; Earnings in 4 days (event risk).

Is ARDT overvalued or undervalued?

Ardent Health, Inc. trades at a P/E of 10.2 (forward 8.4). TrendMatrix value score: 8.6/10. Verdict: Sell.

What do analysts say about ARDT?

19 analysts cover ARDT with a consensus score of 3.9/5. Average price target: $12.

What does Ardent Health, Inc. do?Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the...

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.